- Analysts at Mizuho initiated coverage on Biogen Inc BIIB with a Neutral rating. The price target for Biogen is set to $290. Biogen shares closed at $295.62 on Monday.
- Jefferies initiated coverage on BioScrip Inc BIOS with a Buy rating. BioScrip shares closed at $2.61 on Monday.
- Analysts at Piper Jaffray initiated coverage of Mammoth Energy Services Inc TUSK with an Overweight rating. Mammoth Energy shares closed at $13.61 on Monday.
- Analysts at JP Morgan initiated coverage of Adient PLC ADNT with a Neutral rating. The price target for Adient is set to $55. Adient shares closed at $44.60 on Monday.
- Analysts at Aegis Capital initiated coverage on Nektar Therapeutics NKTR with a Buy rating. The price target for Nektar Therapeutics is set to $21. Nektar Therapeutics shares closed at $12.80 on Monday.
- Mizuho initiated coverage on Amgen, Inc. AMGN with a Buy rating. The price target for Amgen is set to $164. Amgen shares closed at $139.21 on Monday.
- Analysts at Deutsche Bank initiated coverage on Microsemi Corporation MSCC with a Buy rating. The price target for Microsemi is set to $60. Microsemi shares closed at $47.84 on Monday.
- Analysts at Imperial Capital initiated coverage on Newcastle Investment Corp. NCT with an In-Line rating. The price target for Newcastle Investment is set to $4.50. Newcastle Investment shares closed at $4.54 on Monday.
- Analysts at BMO Capital initiated coverage on Sociedad Quimica y Minera de Chile (ADR) SQM with a Market Perform rating. The price target for Sociedad Quimica y Minera de Chile is set to $30. Sociedad Quimica y Minera de Chile shares closed at $29.07 on Monday.
- Mizuho initiated coverage on Celgene Corporation CELG with a Buy rating. The price target for Celgene is set to $130. Celgene shares closed at $107.49 on Monday.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in